Company Search:
Advanced Search
Sponsored Links
Oramed Pharmaceuticals Incorporation Company Snapshot
Oramed Pharmaceuticals Incorporation operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oramed Pharmaceuticals Incorporation with three other pharmaceutical manufacturers in Middle East: Compugen Ltd (2016 sales of 2.72 million Israel Shekels [US$771,546.26 ] of which 100% was Biological Research), D Pharm Limited (293,000.00 Israel Shekels [US$83,027.41 ] ), and BioLight Life Sciences Ltd (2.11 million Israel Shekels [US$598,194.07 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oramed Pharmaceuticals Incorporation
  Stock Performance Chart for Oramed Pharmaceuticals Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (11/17/2017): 31.93
(Figures in Israel Shekels)
1 Week -0.6%   13 Weeks -15.2%  
4 Weeks 8.8%   52 Weeks 26.6%  
Oramed Pharmaceuticals Incorporation Key Data:
  Ticker: ORMP Country: Israel
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 2,467,190
(Year Ending Jan 2017).
Employees: 12
  Currency: Israel Shekels Market Cap: 425,275,442
  Fiscal Yr Ends: August Shares Outstanding: 13,320,962
  Share Type: Ordinary Closely Held Shares: 3,830,441
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.